gsk-2251052

Navitoclax dihydrochloride is a synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity.

Epetraborole hydrochloride (GSK2251052 hydrochloride) 是一个新型 LeuRS 抑制剂，通过绑定 leucyl-tRNA 合成酶终端的腺苷核糖抑制蛋白合成，可研究 Gram-negative 细菌引起的感染。